A Tobacco-Derived Thymosin β4 Concatemer Promotes Cell Proliferation and Wound Healing in Mice

Rylosona Janarthini1, Xiaolei Wang1, Lulu Chen1

  • 1Joint Tomato Research Institute, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai 200240, China; Plant Biotechnology Research Center, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai 200240, China.

Insights

Plant-based production of Thymosin β4 (Tβ4) in tobacco leaves offers a promising alternative to current methods. Tobacco-derived Tβ4 demonstrated superior efficacy in promoting splenocyte proliferation and wound healing compared to commercially sourced or E. coli-derived Tβ4.

Area of Science:

  • Biotechnology
  • Plant molecular biology
  • Immunology

Background:

  • Thymosin β4 (Tβ4) is crucial for tissue repair and regeneration, with significant clinical potential.
  • Existing Tβ4 production methods face limitations in scalability and efficiency.

Purpose of the Study:

  • To evaluate the efficacy of producing recombinant Tβ4 in tobacco plants (Nicotiana tabacum).
  • To compare the therapeutic effectiveness of plant-derived Tβ4 with conventional sources.

Main Methods:

  • Constitutive expression of a codon-optimized Tβ4 gene in tobacco as a 4-unit repeat concatemer fused to a polyhistidine tag.
  • Verification of expression using quantitative PCR and Western blot.
  • Quantification of Tβ4 protein levels via ELISA.
  • In vitro splenocyte proliferation assay and in vivo mouse wound healing model (endothelial migration assay).

Main Results:

  • Successfully generated 14 transgenic tobacco lines expressing 4×Tβ4.
  • Achieved Tβ4 protein concentrations up to 3 μg/g fresh weight in tobacco leaves.
  • Tobacco-derived Tβ4 showed enhanced efficacy in promoting splenocyte proliferation and wound healing compared to commercial or E. coli-derived Tβ4.

Conclusions:

  • Plant-based expression in tobacco is a viable strategy for producing functional Tβ4.
  • Direct administration of plant-derived Tβ4 offers therapeutic advantages.
  • This approach advances the development of plant-derived biopharmaceuticals.